Global Clotrimazole and Betamethasone Diproprionate Drug Market Size, Share and Trends Analysis Report, By Indication (Athlete’s Foot, Jock Itch and Tinea Corporis), By Form (Cream and Lotion), Forecast (2022-2028)

The global clotrimazole and betamethasone diproprionate market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Clotrimazole and betamethasone diproprionate is used in combination to treat fungus infections on different body parts. Growth of fungus on the body is reduced by clotrimazole and betamethasone which is a type of corticosteroid that works on reducing itching, swelling, redness, and discomfort caused by a fungus infection. This combination is helpful in the treatment of ringworm of the foot, ringworm of the groin, and tinea corporis. Sores and blisters are some of the common side effects of this drug.
Rising cases of skin infections or dermatophytosis in past years and its threat are expected to drive the growth of the global clotrimazole and betamethasone diproprionate during the forecast period. According to the Indian Association of dermatologists and venereologists, fungal infections are posing a major threat as if not treated properly. Some major players in the market include Merck & Co., Inc., Glenmark Pharmaceuticals Ltd., and Teva Pharmaceutical Industries Ltd., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market.
Pharmaceutical companies are making their way into new segments and are providing options for the treatment of fungal diseases. For instance, in Sep 2020, CHL Health Ltd. has introduced its new product category for the treatment of fungal infections and skin-related problems. Dermatology is their main focus for the future. The company has launched Clocip which is a skin infection solution. The product is available in two forms, the first is Clocip Clotrimazole Absorbent and the second is Clocip Clotrimazole cream. It is effective in the treatment of athlete’s foot and Jock Itch. Clocip Clotrimazole Absorbent and Clocip Clotrimazole cream are also useful as a topical treatment for nappy rash and sweat rash.

Market Coverage
The market number available for – 2021-2028
Base year- 2021
Forecast period- 2022-2028

Segment Covered-
By Indication
By Form

Regions Covered-
North America
Europe
Asia-Pacific
Rest of the World

Top Major Key Players:
Merck & Co., Inc., Glenmark Pharmaceuticals Ltd., and Teva Pharmaceutical Industries Ltd., among others.

Key questions addressed by the report
What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
How has COVID-19 impacted the market?
Deviation from the pre-COVID-19 forecast
Most affected region and segment
Who is the leader in the market?
How players are addressing challenges to sustain growth?
Where is the investment opportunity?

Global Clotrimazole and Betamethasone Diproprionate Market Report By Segment

By Disease
Athlete’s Foot
Jock Itch
Tinea Corporis

By Form
Cream
Lotion